Imipramine Inhibition of Transient K+ Current: An External Open Channel Blocker Preventing Fast Inactivation  by Kuo, Chung-Chin
Imipramine Inhibition of Transient K Current: An External Open Channel
Blocker Preventing Fast Inactivation
Chung-Chin Kuo
Department of Physiology, National Taiwan University College of Medicine, and Department of Neurology, National Taiwan University
Hospital, Taipei 100, Taiwan, Republic of China
ABSTRACT Rapidly inactivating K current (KA current) is recorded from rat hippocampal neurons by whole-cell patch-
clamp technique and suitable voltage protocols. It is found that imipramine, a commonly prescribed tricyclic antidepressant,
is an open KA channel blocker with a binding rate constant of 5.6  10
6 M1 s1 and an apparent dissociation constant of
no more than 6 M if applied extracellularly in pH 7.4. The inhibitory effect is more pronounced in more alkaline extracellular
solution, suggesting that the neutral form of imipramine is much more active than the charged form. In contrast, intracellular
imipramine shows no inhibitory effect. Furthermore, the inhibitory effect of imipramine is antagonized by external but not
internal K. These findings suggest an imipramine binding site located close to the external pore mouth. It is also found that
the inactivation curve of KA current is not changed by imipramine. Moreover, the recovery of KA current after a step
depolarization is accelerated in the presence of imipramine. These findings suggest insignificant binding of imipramine to the
fast inactivated KA channel. The selective binding of imipramine to only the activated but not the deactivated or inactivated
states seems to suggest continual gating conformational changes in the external pore mouth of these neuronal KA channels
during membrane depolarization.
INTRODUCTION
Imipramine is an important antidepressant agent frequently
prescribed in psychiatric and other clinics. It contains a
characteristic three-ring nucleus and is a member of the
“tricyclic antidepressants.” The therapeutic effect of tricy-
clic antidepressants against depression is most likely ascrib-
able to their modulation of the aminergic (norepinephrine
and serotonin) transmission in the central nervous system
(for a review see Hollister, 1995). Nevertheless, these com-
pounds have also been shown to inhibit K and other ionic
currents (Isenberg and Tamargo, 1985; Ogata and Nara-
hashi, 1989; Delpon et al., 1992; Ogata and Tatebayashi,
1993; Wooltorton and Mathie, 1993, 1995). In this regard, it
is interesting that the inhibition of K currents by imipra-
mine seems to be different in different preparations. In
sympathetic neurons, Wooltorton and Mathie (1993) found
that imipramine had a stronger inhibitory effect on the late,
sustained part of whole-cell K currents than on the early
peak of K currents, as if imipramine preferentially blocks
the delayed-rectifier K current rather than the transient or
A-type K current (KA current). On the other hand, Delpon
et al. (1992) integrated the first 50 ms of K current elicited
upon depolarization instead of measuring just the peak
current and argued that imipramine is a potent blocker of
KA current in cardiac cells.
The foregoing seemingly conflicting observations may be
reconciled if imipramine is an open channel blocker of the
KA currents. In other words, if imipramine has high affinity
toward only the open but not the closed or resting states of
the channel, it would take some time for the current to be
inhibited by the drug after the channel is opened upon
depolarization. Thus imipramine would not decrease the
early peak as much as the late K currents, but would have
a significant effect against the early current if one integrates
the first 50 ms of K current upon depolarization. The
findings that imipramine shortens the time to peak and
increases the decaying rate of the transient K currents also
support the open channel blocking effect of imipramine
(Delpon et al., 1992). Because different affinities of a drug
toward the closed and open states of a channel are conse-
quences of channel gating, the characterization of an open-
channel blocking phenomenon in more detail would not
only be of pharmacological interest, but would also shed
light on the gating conformational changes of the channel. I
therefore studied the mechanisms underlying imipramine
inhibition of KA current in hippocampal neurons with two
goals. First, I would like to examine whether imipramine is
an open channel blocker of the KA current in mammalian
central neurons, and to measure the affinity and kinetics of
imipramine binding to the KA channel to assess its pharma-
cological significance. Second and even more interesting, I
would try to deduce some gating conformational changes of
the channel by investigating the location and nature of the
imipramine binding site. It is found in this study that imip-
ramine preferentially blocks the open KA channels with an
apparent dissociation constant of no more than 6 M in pH
7.4, and the inhibitory effect of imipramine is stronger in
more alkaline solution. The imipramine “receptor” is prob-
ably located close to the external pore mouth and consists of
one aromatic and one aliphatic molecular determinant, im-
plying gating conformational changes involving amino ac-
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ids containing such side-chain groups. Moreover, although
imipramine is an open KA channel blocker from the outside,
imipramine binding and fast inactivation of the channel
seem to be mutually exclusive. This further suggests differ-
ent conformations near the external pore mouth between the
open and fast inactivated states of central neuronal KA
channels.
MATERIALS AND METHODS
Cell preparation
Coronal slices of the whole brain were prepared from 7- to 14-day-old
Long-Evans rats. The CA1 region was dissected from the slices and cut
into small chunks. After treatment for 5–10 min at 37°C in dissociation
medium (in mM, 82 Na2SO4, 30 K2SO4, 3 MgCl2, 5 HEPES, and 0.001%
phenol red indicator, pH 7.4) containing 0.5 mg/ml trypsin (type XI;
Sigma, St. Louis, MO), tissue chunks were moved to dissociation medium
containing no trypsin but 1 mg/ml bovine serum albumin (Sigma) and 1
mg/ml trypsin inhibitor (type II-S; Sigma). Each time when cells were needed,
two or three chunks were picked and triturated to release single neurons.
Whole-cell recording
The dissociated neurons were put in a recording chamber containing
Tyrode’s solution (in mM, 150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, and 10
HEPES, pH 7.4). Whole-cell voltage-clamp recordings were obtained
using pipettes pulled from borosilicate micropipettes (OD 1.55–1.60 mm;
Hilgenberg, Malsfeld, Germany), fire polished, and coated with Sylgard
(Dow-Corning, Midland, MI). Except for the internal imipramine experi-
ments in Fig. 4 and the low internal K experiments in Fig. 5, the pipettes
were filled with the standard internal solution, containing (in mM) 75 KCl,
75 KF, 2.5 MgCl2, 5 HEPES, 5 EGTA, with pH adjusted to 7.4 by KOH.
For the experiments studying the effect of internal imipramine in Fig. 4,
100 M imipramine was added to the standard internal solution. In Fig. 5
B, the “15 mM internal K solution” contained the same components as the
standard internal solution, except that (in mM) 75 KCl  75 KF was
replaced by 15 KCl  60 NMGCl (N-methyl-D-glucamine chloride)  75
NMGF (N-methyl-D-glucamine fluoride). A seal was formed and the
whole-cell configuration was obtained in Tyrode’s solution. The cell was
then lifted from the bottom of the chamber and moved in front of an array
of flow pipes (microcapillary, content 1 l, length 64 mm; Hilgenberg)
emitting external recording solutions. Except for the “150 mM external
K” experiments in Fig. 5, the external solutions were basically Tyrode’s
solutions (pH 5.8–8.2 for the experiments in Fig. 6, pH 7.4 for the other
experiments) with or without different concentrations of drugs. The 150
mMK external solution used in Fig. 5 was made by changing the 150 mM
NaCl  4 mM KCl in Tyrode’s solution to 150 mM KCl  4 mM NaCl,
with all other components kept the same. Imipramine, benztropine, diphen-
hydramine, and tranylcypromine were dissolved in water, and other drugs
were dissolved in dimethylsulfoxide to make a 100 mM stock solution,
which was then diluted into Tyrode’s or 150 mM K external solution to
attain the final concentrations desired. The final concentration of dimeth-
ylsulfoxide (0.1% or less) was not found to have a detectable effect on K
currents. All external solutions contained 1 M tetradotoxin to block the
sodium currents. The Ca2 currents in these preparations tended to run
down so quickly and completely (possibly because of the fluoride ions in
the internal solution) that almost no Ca2 currents were detectable 3 min
after establishment of the whole-cell configuration. Some sustained or
“late” K currents also ran down in a few minutes, presumably because of
the reduction of Ca2-dependent K currents when the intracellular space
was dialyzed with EGTA. Thus I always waited for at least 5–10 min after
the establishment of whole-cell configuration to start the recording. In this
way organic or inorganic Ca2 channel blockers are spared to avoid
unnecessary drug-drug interaction or modulation of the KA currents. Cur-
rents were recorded at room temperature (25°C) with an Axoclamp 200A
amplifier, filtered at 5 kHz with a four-pole Bessel filter, digitized at
100–300-s intervals, and stored using a Digidata-1200 analog/digital
interface and pCLAMP software (Axon Instruments, Foster City, CA).
Residual series resistance was generally smaller than 1 M after partial
compensation (typically more than 80%), and the product of residual series
resistance and cell capacitance was generally less than 20 s. All statistics
are given as mean  SEM.
RESULTS
Imipramine speeds the decay of transient K
current but does not affect its activation phase
Fig. 1 A shows the dose-dependent inhibitory effect of
imipramine on the macroscopic K currents elicited by a
step depolarization. The decay of the currents is speeded by
imipramine, and the inhibition of the late currents seems
more pronounced than the inhibition of the early peak
currents. As the current under observation here is a mixture
of different kinds of K currents, there are two possible
causes of the acceleration of current decay: imipramine
could be an open channel blocker of some rapidly activating
K currents, or it could be a selective inhibitor of some late
currents. To have a purer population of currents, I try to
isolate the KA current from the delayed rectifier and other
late K currents by a pulse protocol in Fig. 1 B (see also
Numann et al., 1987; Wooltorton and Mathie, 1993). An
advantage of using a voltage protocol rather than a pharma-
cological formula here is that unnecessary interactions
among different drugs can be avoided. The KA current
isolated in this way activates fast, reaching its peak within
3–4 ms of depolarization to 100 mV, and then shows an
inactivating time constant around 20 ms. (About 30% of the
cells do show a longer inactivating time constant by this
pulse protocol. However, only those that show a time con-
stant less than 25 ms are used for further studies.) There is
still a “sustained” component of such KA current. This
sustained component may consist of both truly noninacti-
vating current through KA channels (e.g., Timpe et al.,
1988; Iverson et al., 1988) and the “contaminating” delayed
rectifier or other late K currents. Imipramine not only
speeds KA current decay and inhibits the current, but also
shows a dose-dependent shortening of the time to peak
current (Fig. 1 B). The early activation phase of the currents,
however, is almost unaffected by imipramine. All of these
findings suggest that imipramine binds to and blocks the
pore only when the KA channel is open. Similar findings are
also obtained in those cells showing prominent KA current
upon a simple depolarizing pulse (Fig. 1 C), arguing against
any significant artifact associated with the pulse protocol
used to isolate the KA current.
The rate of decay of transient K current is
linearly related to imipramine concentrations only
when the concentrations are not high
If imipramine is an open channel blocker of KA current,
then the accelerated decay of the current would be mostly
2846 Biophysical Journal Volume 12 December 1998
related to drug binding (the O to OB step in the simplified
scheme in Fig. 2 A). When the activation step or C to O rate
is made very fast by strong depolarization (e.g., to 100
mV), the O to OB step may become rate limiting in the
whole “reaction,” and the observed kinetics of current decay
should be positively correlated with drug concentrations.
Fig. 1 D shows this is indeed the case when imipramine
concentrations are not high. The linear relationship at the
low concentration range further suggests a one-to-one bind-
ing (simple bimolecular reaction) between imipramine and
KA channels. The slope of the regression line, 5.6  10
6
M1 s1, can be viewed as the binding rate constant be-
tween imipramine and the open KA channel. Interestingly,
at concentrations 100 M or higher, the observed macro-
scopic binding rates of imipramine fall below the prediction
by the regression line. This is actually consistent with rather
than in contradiction to the notion that imipramine blocks
open KA channels via a simple bimolecular reaction. In the
control condition, the activation of KA current in the exper-
iments in general has a time constant of 0.7–1 ms. Simplis-
FIGURE 1 Dose-dependent inhibition of K currents by imipramine. (A) K currents in controls and 3, 10, 30, or 100 M imipramine (denoted by each
trace) in a cell held at 120 mV and stepped every 3 s to 100 mV for 450 ms to elicit the current. Dashed line, zero current level. (B) The KA current
is isolated by a pulse protocol shown in the upper panel. Specifically, the cell is held at 50 mV and then hyperpolarized to 120 mV for 50 ms before
it is stepped every 2 s to 100 mV for 100–200 ms to elicit the current. (C) Some cells show prominent KA current with just a simple pulse protocol. For
example, this cell is held at 120 mV and stepped every 2 s to 100 mV for 115 ms to elicit the current. Note that the effects of 3–100 M imipramine
are quite similar to those observed in B. (D) The inverses of the decaying time constants of the currents in B from six cells are (in ms1) 0.055  0.006
(control), 0.069  0.007 (3 M), 0.12  0.012 (10 M), 0.21  0.02 (30 M), 0.43  0.05 (100 M), and these values are plotted against imipramine
concentration. The line is a linear regression fit to the first four mean values (0–30 M imipramine). The intercept and the slope are 0.056 ms1 and 5.6 
106 M1 s1, respectively.
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tically this would imply a C to O rate around 1000 s1 in
Fig. 2 A. According to the slope of the regression line, 100
M imipramine would yield an O to OB rate around 600
s1. These numbers indicate that the O to OB step is no
longer so “rate limiting” for the overall reaction. The ob-
served rate of current decay would thus be slower than the
“true” O to OB rate because of the slow supply of state O,
the “reactant” of the O to OB step. These concepts are
recapitulated by the simulated currents in Fig. 2, B and C.
The affinity between imipramine and the open
KA channel
As the interaction between imipramine and the open KA
channels in hippocampal neurons seems to be a simple
bimolecular reaction, it is desirable to estimate the dissoci-
ation constant between the two molecules. However, if one
measures the percentage of inhibition early in the step
depolarization, the drug binding reaction has not reached its
steady state. If one measures the percentage of inhibition
late in the step depolarization, the current may be contam-
inated by the delayed rectifier or other late K currents. I
therefore measure both the degree of inhibition at three time
constants of current decay at each drug concentration (Fig.
3 A) and at 100 ms of depolarization (Fig. 3 B). Both yield
a dissociation constant of 6 M. This value should be
viewed as a high estimate of the dissociation constant (low
estimate of the affinity) between imipramine and the open
KA channels in hippocampal neurons. This is because in
Fig. 3 A the blocking reaction may still slightly fall short of
the steady state, and in Fig. 3 B the measurement may be
contaminated by the delayed rectifier current and a “truly”
FIGURE 2 Simulation of the inhibitory effect of
imipramine on KA currents. (A) A simplified gating
model for KA channels depicting the open channel
blocking effect of imipramine. After the channel is
opened at depolarization, the pore may subsequently
become nonconducting because of either channel
inactivation (state I) or imipramine binding (state
OB). Two other nonconducting states CB and IB,
whose existence is discussed in more detail later, are
temporarily disregarded here. k1 to k6 denote the rate
constant of each reaction. (B) Simulated currents
based on the scheme in A. k1, k2, k3, k4, and k6 are (in
s1) 800, 1, 40, 10, and 18, respectively. k5 is 6 
106 M1 s1 times imipramine concentrations (0, 3,
10, 30, or 100 M). The opening probability (occu-
pancy of the O state) at each time point is calculated
by the Runge-Kutta method, and the final current at
each time point is set as the product of opening
probability and 15 nA (an arbitrarily defined value
for the current when all channels are open). Dashed
line: zero current level. (C) The inverses of the
decaying time constants of the currents in B are
plotted against imipramine concentrations. The line
is a linear regression fit to the first four points (0–30
M imipramine). The intercept and the slope are
0.051 ms1 and 5.6  106 M1 s1, respectively.
Note that the point at 100 M imipramine deviates
from the line as in Fig. 1 D.
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noninactivating K current. The delayed rectifier current
seems to be less sensitive to imipramine (dissociation con-
stant 7 M; see Wooltorton and Mathie, 1993). The
noninactivating K currents may manifest themselves as
small currents elicited by a test pulse to 100 mV directly
from a holding potential of 50 mV and are essentially
insensitive to imipramine (data not shown).
Imipramine has no effect on the KA current if
applied internally
In previous experiments imipramine is applied externally
(from the extracellular side). However, the uncharged form
of imipramine might cross the membrane easily. Because
both the internal and external solutions are at pH 7.4, and
there is no continuous and rapid “wash” of the intracellular
space, intracellular imipramine concentration may build up
or even become as high as that in the external solution.
Therefore based on only the previous experiments, one
cannot tell whether the externally applied imipramine
blocks the open KA channel from the outside or from the
inside. Taking advantage of the rapid and continuous solu-
tion change of the extracellular space in the experimental
system, I examine the effect of internal imipramine by
adding 100 M imipramine to the pipette solution. Now the
imipramine crossing the membrane and reaching the outside
will be quickly washed away, and thus the internally applied
imipramine should not build up any significant concentra-
tion in the external solution. Very similar to the findings
with drug-free internal solution, in the first few minutes
after breakthrough into the cell, the late currents become
smaller (see Materials and Methods). However, there is no
significant reduction of the early K current throughout the
experiments (up to 90 min), and the current amplitude is
always comparable to those observed with drug-free inter-
nal solution. Moreover, the speed of current decay and the
inhibition produced by 10 M external imipramine are very
similar whether the internal solution contains 100 M imip-
ramine or not, confirming that the KA current observed in
the presence of internal imipramine is not a residual current
already under significant inhibition (Fig. 4 A–C). These
findings suggest that imipramine blocks the KA channel
pore from the outside rather than from the inside.
The inhibitory effect of imipramine on the KA
current is antagonized by external but not
internal K
If imipramine blocks the pore of open KA channels, then it
would be interesting to see whether there is any interaction
between the blocking imipramine and other travelers in the
pore, e.g., K ions. The inhibition by imipramine seems to
be unchanged if the internal K concentration is decreased
from 150 to 15 mM. However, the inhibition is significantly
reduced when external K is increased from 4 to 150 mM
(Fig. 5, A and B). Fig. 5 C shows that the binding rate
constants are also reduced in 150 mM external K. These
findings not only support the foregoing view that imipra-
mine blocks the KA channel pore from outside, but also
suggest that the imipramine binding site may be located
quite superficially in the pore (see the Discussion).
The inhibitory effect of imipramine is more
pronounced in more alkaline solution
Imipramine has a pKa of 9.5, and thus in aqueous solution
it can be protonated and becomes a charged molecule.
Wooltorton and Mathie (1995) have shown that the un-
charged form of amitriptyline (another commonly pre-
scribed tricyclic antidepressant also containing a tertiary
amine side chain) is probably the active form responsible
for the blockade of delayed rectifier K currents. To see
whether the neutral form of imipramine is also more active
than the charged (protonated) form in blocking the KA
current, the effect of imipramine is examined in solutions of
pH 5.8, 6.6, and 8.2 (Fig. 6). The effect of imipramine in pH
FIGURE 3 Affinity between imipramine and KA channels. KA current is
recorded with the pulse protocol in Fig. 1 B. (A) The current at three time
constants of current decay in the presence of imipramine is normalized to
the control current at the same time point in six cells and is plotted against
the concentration of imipramine, [imipramine]. The line is a best fit to the
data points of the form: relative current  0.05  (1  0.05)/[1 
([imipramine]/5.9 M)]. (B) In the same cells as in A, the current at 100 ms
of depolarization in the presence of imipramine is normalized to the control
current at the same time point and is plotted against [imipramine]. The line
is a best fit to the data points of the form: relative current  0.14  (1 
0.14)/[1  ([imipramine]/6.7 M)].
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9.0 or higher is not documented because of apparent
changes of the whole-cell K currents in those very alkaline
solutions. (The “transient” K current becomes quite small,
FIGURE 5 The inhibitory effect of imipramine on KA current is antag-
onized by external K. (A) The inhibitory effect of 10 and 100 M external
imipramine in Tyrode’s solution (which contains 4 mM K, upper panel)
is larger than that in 150 mM K external solution (lower panel). The
sweeps are from the same cell, and the pulse protocol is the same as that
in Fig. 1 B. The internal solution contains 150 mM K (standard internal
solution). Dashed lines, Zero current level. (B) In each of the three different
experimental conditions, i.e., external 4 mM K/internal 150 mM K,
external 4 mM K/internal 15 mM K, and external 150 mM K/internal
150 mM K, the relative currents in 10 M imipramine are defined by the
same method as that in Fig. 3 B and are 0.54  0.05 (n  4), 0.57  0.05
(n  5), and 0.8  0.03 (n  4), respectively. In 100 M imipramine, the
relative currents are 0.32 0.05, 0.33 0.03, and 0.59 0.06 in (external
K/internal K in mM) 4/150, 4/15, and 150/150, respectively. (C) The
data in external 4 mM K/internal 150 mM K and in external 150 mM
K/internal 150 mM K in B are from the same cells. In all four of the
cells, the binding rate constants are always smaller in 150 mM external K
(Œ) than in 4 mM external K (E).
FIGURE 4 Internal imipramine has no effect on KA currents. (A) KA
current is recorded with the same pulse protocol as that in Fig. 1 B, but here
the internal solution contains 100 M imipramine. The currents are ob-
tained 20 min after establishment of the whole-cell configuration in the
presence of either 0 (control) or 10 M external imipramine (denoted by
the traces). Dashed line: zero current level. (B) With 100 M internal
imipramine, the relative current at 100 ms of depolarization in 10 M
external imipramine (normalized to that in zero external imipramine, black
bar) is 0.47  0.03 (n  4). As a comparison, the relative current with no
imipramine inside is 0.51  0.02 (white bar, data from Fig. 3 B). (C) The
decaying rates of KA current in the absence of external imipramine are
0.05  0.007 (n  4, black bar a) and 0.055  0.006 ms1 (n  6, white
bar b, data from Fig. 1 D) for 100 M and zero internal imipramine,
respectively. In the presence of 10 M external imipramine, the decaying
rates of KA current are 0.11  0.02 (n  4, black bar c) and 0.12  0.012
ms1 (n 6, white bar d, data from Fig. 1 D) for 100 M and zero internal
imipramine, respectively.
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and its decaying time constant is usually quite longer than
25 ms, the cut line for identification and selection of KA
currents in this study.) Fig. 6 A shows that the inhibition by
imipramine is pH dependent and is stronger in more alkaline
solutions. Consistent with this finding, the peak KA current
is always reached earlier in higher pH with the same (total)
concentration of imipramine (data not shown), and the macro-
scopic binding rate constant is smaller in lower pH (Fig. 6 B).
The findings in Fig. 6, A and B, strongly imply that the
neutral form of imipramine is more active than the charged
form. Unfortunately, in Fig. 6 A the KA currents in pH 5.8
and 6.6 are so incompletely inhibited, even with 900 M
(total) imipramine, that it is not feasible to have a reliable fit
to determine the dissociation constant in these acidic solu-
tions. An alternative method is therefore used to make a
rough estimate of the relative strengths of different forms of
imipramine (Fig. 4 C). Assuming both neutral and charged
forms of imipramine bind to the same receptor, and the
maximum inhibition produced by imipramine in our prep-
aration is 86% (0.14 relative current with saturating con-
centrations of imipramine in Fig. 3 B), we may have
relative current
 0.14 0.86/	1 
I/Kd,I 
IH/Kd,IH
(1)
where [I] and [IH] are the concentrations of neutral and
charged forms of imipramine, respectively, and Kd,I and
Kd,IH are the dissociation constants of the neutral and
charged form of imipramine, respectively. Given a pKa
value 9.5 for the protonated imipramine, we have

IH 	1/	1 10up	9.5 pH  
imipramine (2)
and

I 	10up	9.5 pH/
	1 10up	9.5 pH  
imipramine
(3)
where [imipramine] represents the total concentration of
imipramine. Fig. 6 C plots the relative current in the pres-
ence of 30, 100, and 300 M imipramine against the pH of
the solution. The relative current could be reasonably ap-
proximated by Eqs. 1–3 with Kd,I fixed at 0.2 M and Kd,IH
set at 500, 1200, and 2000 M for the data in 30, 100, and
300 M imipramine, respectively. Although these valuesFIGURE 6 The inhibitory effect of imipramine is more pronounced in
more alkaline solution. (A) Measurements similar to those in Fig. 3 B are
repeated in external solutions of pH 5.8 (n  6), 6.6 (n  6), and 8.2 (n 
8). The current at 100 ms of depolarization in the presence of imipramine
is normalized to the control current at the same time point and is plotted
against the (total) concentration of imipramine. The external Tyrode’s
solution is adjusted to the desired pH with HCl or NaOH. The pH 5.8
solution may contain 5 mM 2-[N-morpholino]ethanesulfonic acid as an
additional buffer (the results are very similar whether the additional buffer
is added or not, and data from both conditions are used indiscriminately for
statistics). Only cells showing transient K current with a decaying time
constant less than 25 ms are used. Along with the data in pH 7.4 in Fig. 3
B, the inhibitory effect of imipramine on KA current is clearly stronger in
more alkaline solutions. (B) Measurements similar to those in Fig. 1 D are
repeated in external solutions of pH 5.8–8.2. The inverses of the decaying
time constants are plotted against the (total) concentration of imipramine.
The cell numbers are the same as those in A. The lines are linear regression
fits to the data obtained in 0–300 M imipramine, 0–100 M imipramine,
and 0–30 M imipramine for pH 5.8, 6.6, and 8.2, respectively. The
intercepts of the lines are 0.07, 0.08, and 0.04 ms1, and the slopes are
0.48  106, 1.35  106, and 8.0  106 M1 s1 for pH 5.8, 6.6, and 8.2,
respectively. It is interesting to note that the linearity of the data tends to
reach a higher concentration range in more acidic solutions, which is
consistent with the faster macroscopic binding rates in more alkaline
solutions. (C) The relative current in the presence of 30, 100, or 300 M
imipramine is plotted against the pH of the solution; data are from A and
Fig. 3 B. The lines are drawn by Eqs. 1, 2, and 3, with the dissociation
constant between the neutral form of imipramine and the KA channel set to
0.2 M and the dissociation constant between the protonated form of
imipramine and the channel set to 500-2000 M (see text for details).
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should only be regarded as rough estimates of Kd,I and
Kd,IH, it seems reasonable to conclude that the dissociation
constant between the neutral form of imipramine and the KA
channel is in the submicromolar range, whereas the affinity
between the charged form of imipramine and the channel is
very much lower.
Similar inhibitory effect on the KA current by
other drugs
Imipramine contains a tricyclic nucleus and a three-carbon
amine side chain. To explore the major structural determi-
nants for imipramine binding to the open KA channel, I
studied the effect on the KA current of several other com-
pounds (Fig. 7 A). Diphenhydramine is an antihistamine
with two phenyl groups and a “side chain” comparable in
size to that of imipramine. Benztropine is an anticholinergic
with two phenyl groups and a cyclic side chain. Although
neither diphenhydramine nor benztropine has a tricyclic
structure, they both show a strong inhibitory effect on the
KA current very similar to that of imipramine (Fig. 7 B). The
inhibited currents also display the same key features, such
as shortened time to peak and accelerated current decay.
Thus two separate phenyl groups may be as effective as the
FIGURE 7 Inhibition of KA current
by other drugs. (A) Structure of some of
the drugs tested. (B) KA current is ob-
tained in one cell by the same protocol
as in Fig. 1 B. Diphenhydramine, benz-
tropine, and tranylcypromine at 10–100
M all produce significant inhibition of
the current. Dashed lines, Zero current
level.
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tricyclic structure in supporting drug binding to the open KA
channel. On the other hand, neither 100 M carbamazepine,
an anticonvulsant and antidepressant with a tricyclic struc-
ture but only a very short amide side chain, nor 100 M
lamotrigine, a new anticonvulsant with two aromatic rings
but no side chain, shows any significant inhibitory effect on
the KA current (data not shown). These findings suggest an
important role of the side chain. Most interestingly, tranyl-
cypromine, an antidepressant with only one phenyl group
and a “triangular” side chain, shows significant inhibition of
the KA current (although the effect is less potent than those
of imipramine, diphenhydramine, or benztropine; Fig. 7 B).
Yet both 100 M benzamide, a simpler compound with a
phenyl group plus a very short amide side chain, and 100
M n-butylamine, a four-carbon amine with no aromatic
groups, fail to inhibit KA current significantly (data not
shown). All together the findings in Figs. 6 and 7 suggest
that there may be two essential structural parts to the drug-
channel interaction, the phenyl group and the three- to
four-carbon aliphatic (amine) chain, with the latter most
favorably in the neutral form.
Imipramine does not bind to the inactivated
KA channel
The KA current is a transient current because the channel
tends to be rapidly inactivated when it is open. Being a
consequence of channel activation, the inactivated state may
share some common conformations with the open state. It
would therefore be interesting to see whether imipramine,
an open channel blocker, also binds to the inactivated chan-
nels. If imipramine also has significant affinity toward the
inactivated KA channels, then the inactivation curve should
be shifted by imipramine because of the occupancy of state
IB (Fig. 2 A). This argument is similar to the cases of local
anesthetics (e.g., lidocaine) or anticonvulsants (e.g., phenyt-
oin) that have high affinities toward the inactivated Na
channels (Bean et al., 1983; Kuo and Bean, 1994). Fig. 8
shows the inactivation curve of KA current in hippocampal
neurons. This curve, however, is not shifted in the presence
of 10–30 M imipramine, suggesting little occupancy of
state IB in up to 30 M imipramine. Compared to the
affinity between imipramine and the open state (dissociation
constant no more than 6 M in pH 7.4), the affinity between
imipramine and the inactivated state seems much smaller.
The occupancy of state IB can also be checked from a
kinetic point of view. If there is significant occupancy of
state IB in the presence of imipramine, then the recovery
from “inactivation” in such a condition (recovery mainly
from state IB) should be slower than the recovery in the
control condition (recovery entirely from state I). This is not
the case in Fig. 9, where the recovery from “inactivation” is
not slower, but is even faster, in the presence of imipramine.
The faster recovery in imipramine further supports the con-
cept that imipramine binding and channel inactivation are
mutually exclusive in these neuronal KA channels (see the
Discussion).
DISCUSSION
Imipramine: an open KA channel blocker
There are different kinds of K currents in mammalian
central neurons (for a review see Aronson, 1992). In this
study I have focused on the KA or fast transient K
 current,
which activates rapidly within a few milliseconds and then
inactivates within a few tens of milliseconds. In the pres-
ence of imipramine, the peak of KA current was reduced in
amplitude, yet was reached earlier (than in control) and was
followed by an accelerated decay. Moreover, the speed of
current decay was linearly correlated with imipramine con-
centration when the concentration was not high. These
findings suggest that imipramine blocks open KA channels,
possibly through a one-to-one binding reaction. Further-
more, in the continuous presence of imipramine, although
the current has decreased to a low steady-state level at the
end of a test pulse (for example, in the experiments in Fig.
1 B), the same high peak current is always present at the
next test pulse. This means that the imipramine molecule
bound to the open channel pore during the test pulses must
unbind during the intervening hyperpolarization (see below
for more discussion on the unbinding processes). Overall, it
is concluded that imipramine has a much higher affinity for
the open channel than for the closed or resting channels.
FIGURE 8 The inactivation curve of KA current. The cell is held at
120 mV and stepped every 5 s to the inactivating pulse (130 to 10
mV) for 450 ms before being stepped to a test pulse at80 mV for another
450 ms. The difference between the peak and the end current during the test
pulse after each inactivating pulse is normalized to that after an inactivating
pulse at 120 mV to yield the available fraction of KA current, which is
plotted against the voltage of the inactivating pulse. The lines are fits of a
Boltzmann function 1/(1  exp[(V  Vh)/k]), with Vh values of 71.1,
69.4,71.7, and70.2 mV and k values of 10.9, 10.5, 10.3, and 10.8 for
the four sets of data in control (before imipramine), 10 M imipramine, 30
M imipramine, and control (after imipramine), respectively.
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The active form of imipramine
Using a permanently charged analog of amitriptyline (N-
methylamitriptyline), Wooltorton and Mathie (1995) argued
that the unprotonated (uncharged) form of tricyclic antide-
pressants represents the active form inhibiting late K cur-
rents. Consistent with this argument, I found that the inhib-
itory effect of imipramine on KA current is pH-dependent
and becomes more pronounced in more alkaline solutions
(Fig. 6 A). A rough estimate of the dissociation constant
between the neutral form of imipramine and the KA chan-
nels is 0.2 M, whereas the affinity between the proton-
ated form and the channel probably is 1000-fold lower (Fig.
6 C). The much higher affinity of the neutral form of
imipramine implies that ionic bonds probably do not play a
significant role in the imipramine–KA channel interaction.
This may shed light on the structure of the imipramine
receptor in central neuronal KA channels (see below).
Location of the imipramine binding site
The binding rate of imipramine to the open KA channel is
slowed by external but not internal K. External K ion
may decrease the on rate of imipramine either by binding to
the doorway of the imipramine receptor or by competing for
the same receptor with imipramine. If the doorway of the
imipramine receptor is blocked by K, then based on the
rationales of simple bimolecular reaction one would expect
a similar decrease in both the binding and unbinding rates.
Thus the steady-state inhibition of KA current may not be
significantly changed. On the other hand, if K and imip-
FIGURE 9 Recovery of KA current from inactivation and imipramine block at 120 mV. (A) The cell is held at 120 mV and stepped every 5 s to an
inactivating pulse at 80 mV for 450 ms. The cell was then stepped back to a recovery gap potential at 120 mV for variable length before being stepped
again to a test pulse at 80 mV for another 450 ms. The difference between the peak and the end current during the test pulse is normalized to that during
the inactivating pulse to yield the fraction recovered, which is then plotted against the duration of the gap recovery potential. The lines are two-exponential
fits to the two sets of data and are of the form: fraction recovered  1  0.44exp(t/17.4 ms)  0.56exp(t/128 ms) (in control, t denotes duration of
the gap potential in ms) and fraction recovered  1  0.51exp(t/11.3 ms)  0.49exp(t/109 ms) (in 30 M imipramine). (B) The fraction of the fast
component of recovery from four cells is 0.42  0.06 (in control) and 0.47  0.09 (in 30 M imipramine). (C) The fast time constant of recovery from
the same four cells is 18.3  2.1 ms (in control) and 11.4  1.5 ms (in 30 M imipramine). (D) The slow time constant of recovery from the same four
cells is 139  30 ms (in control) and 110  16 ms (in 30 M imipramine).
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ramine are competing for the same site, one probably should
observe reduced inhibition in high external K because the
binding rate of imipramine would be decreased but the
unbinding rate may be relatively unaltered. The reduced
inhibition of KA current by imipramine in high external K

(Fig. 5) would therefore imply a common binding site for
external K and imipramine.
Unlike external K, internal K does not seem to com-
pete with imipramine for a binding site in the pore. This
implies that although the binding site is in the pore (because
imipramine is an open channel blocker), it can hardly be
occupied by internal K ion in our experiments. In view of
the fact that the experimental K currents are always out-
ward, the site then must be separated from the extracellular
solution by a very small energy barrier (in terms of the
movement of K ions) but separated from the intracellular
solution by high energy barriers. The K ion in the site then
could have a much stronger tendency to go outside than
inside to make the outward currents. This would suggest
that this imipramine and K ion binding site in the pore is
located close to the external rather than the internal side.
The finding that only extracellular but not intracellular
imipramine produces significant inhibition of the KA cur-
rent is consistent with such concepts. In Fig. 6 B the mea-
sured macroscopic binding rate constant approaches 107
M1 s1 in the solution of pH 8.2. This is a fairly fast
binding rate constant for a macromolecule such as imipra-
mine, and the binding rate constant for the neutral form of
imipramine conceivably may be even faster. This would
also support a superficial location of the drug binding site.
Nature of the imipramine binding site
It is found that 10–100 M diphenhydramine, benztropine,
and tranylcypromine all inhibited KA current with features
similar to those of imipramine. On the other hand, 100 M
carbamazepine, lamotrigine, benzamide, and n-butylamine
did not have a significant effect on KA currents. It seems
that the tricyclic structure is not essential. Instead, a planar
phenyl group plus a three-carbon amine side chain in ap-
propriate conformation may represent the minimum require-
ment for effective binding to the open KA channel pore. On
the other hand, the more potent inhibition by imipramine,
diphenhydramine, and benztropine than by tranylcypromine
further suggests that a second phenyl group in an appropri-
ate position and/or the terminal tertiary amine group (which
yields a much higher hydrophobic bonding constant than the
primary amine group; Zimmerman and Feldman, 1989) may
contribute to a stronger binding.
The structure of imipramine does not favor significant
hydrogen bond formation. Furthermore, the finding that the
neutral form of imipramine is much more effective than the
charged form argues against a significant ionic bond be-
tween imipramine and the KA channel. Excluding ionic and
hydrogen bonds, noncovalent binding between drug and
biomacromolecules is mostly a hydrophobic bond (which
represents a freeing of water molecules and a gain in en-
tropy) or a (induced) dipole-induced dipole bond (London
forces or Debye forces; for a review see Zimmerman and
Feldman, 1989) in nature. A rough estimate of the dissoci-
ation constant between the neutral form of imipramine and
the open KA channel is 0.2 M (Fig. 6 C), which may be
translated into a binding energy of 15.5RT or 9.2 kcal/
mol. This figure is somewhat larger than the usual bond
energy for a hydrophobic bond or an induced-dipole bond
(1–7 kcal/mol; Zimmerman and Feldman, 1989). This is
consistent with the notion that at least two such bonds are
responsible for the binding of imipramine. Because effec-
tive hydrophobic and induced-dipole bonds both require
close proximity between the binding counterparts, the pla-
nar benzene ring would tend to form a bond with the other
planar benzene ring, and the aliphatic group would tend to
cluster with other aliphatic groups. I therefore propose that
the receptor for imipramine in the open KA channel pore
consists of one or two aromatic sites and one aliphatic site
(Fig. 10 A). The aromatic site should be composed of
aromatic amino acids. The aliphatic site is possibly a short
slot that may accommodate uncharged propylamine-like
side chains. In this regard it is interesting that external K
competes with imipramine for some binding ligands. Al-
though K ion is unlikely to compete with imipramine for
the aliphatic site, K ion has been proposed to interact
favorably with the electron-rich face of an aromatic ring
(cation- interaction; Miller, 1993; Kumpf and Dougherty,
1993).
Implications for the gating conformational
changes of central neuronal KA channels
The inactivation curve of KA current is not shifted in 30 M
imipramine (Fig. 8), and recovery from inactivation is faster
in the presence of imipramine (Fig. 9). The latter is also
consistent with previous reports that external K could
speed the recovery of inactivated KA channels (Demo and
Yellen, 1991; Gomez-Lagunas and Armstrong, 1994; Levy
and Deutsch, 1996; Kuo, 1997), given the finding that
external K competes with imipramine for binding to the
open channel pore (Fig. 5). All together these findings
suggest insignificant binding of imipramine to the inacti-
vated state of KA channels (little occupancy of state IB in
Fig. 10 B). There are at least two types of inactivation in KA
channels. N-type inactivation results from binding of an
inactivating particle to the internal pore mouth of the acti-
vated channel (Armstrong and Bezanilla, 1977; Armstrong,
1981; Hoshi et al., 1990; Zagotta et al., 1990), and C-type
inactivation involves conformational changes at the external
pore mouth (Hoshi et al., 1991; Choi et al., 1991; Lopez-
Barneo et al., 1993; Ogielska et al., 1995; Liu et al., 1996).
The negligible binding of imipramine, an external open
channel blocker, to the inactivated state suggests that the
conformation of the external pore mouth is different in the
two gating states. The inactivated state under consideration
here thus seems to have the character of C-type inactivation.
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In this regard it is interesting to note that the fast time
constant of recovery in control is just 18 ms (Fig. 9). This
is consistent with the reported time constants of recovery
from N-type inactivation (Demo and Yellen, 1991; Gomez-
Lagunas and Armstrong, 1994; Kuo, 1997), yet is much
shorter than many reported time constants of recovery from
C-type inactivation (Hoshi et al., 1991; Rasmusson et al.,
1995; Levy and Deutsch, 1996; but in some alternatively
spliced Shaker channel variants the recovery from C-type
inactivation may be quite fast, see Hoshi et al., 1991). Thus
at the end of the inactivating pulse in Fig. 9, many neuronal
KA channels are in a “fast” inactivated state. This state
could be an N-type inactivated state that is also conforma-
tionally different from the open state in the external pore
mouth or a C-type inactivated state that recovers very
quickly at 120 mV. In either case the finding that imip-
ramine selectively binds to only the activated but not the
deactivated or inactivated states is suggestive of interesting
gating conformational changes in the external pore mouth of
these neuronal KA channels. It seems that the external pore
mouth of the channel continues to change its conformation
during membrane depolarization. The receptor for imip-
ramine is produced at first but would subsequently be
destroyed.
The faster recovery in the presence of imipramine (Fig. 9)
also has implications for the existence of state CB (Fig. 10
B). If recovery from state I has a fast time constant of 18
ms, recovery from state OB must proceed with a speed no
slower than90 s1 (the inverse of11 ms) to make a fast
time constant of 11 ms for the macroscopic recovery in
the presence of imipramine (Fig. 9 C). However, given a
macroscopic binding rate of 5.6  106 M1 s1 and a
dissociation constant of no more than 6 M between imip-
ramine and the open KA channel, the OB to O rate in Fig. 10
B cannot be faster than 33 s1. Thus there must be a
recovery route other than OB to O during repolarization. It
seems that the most straightforward choice in the simplified
scheme is the OB to CB to C route. In other words, although
there is little steady-state occupancy of state CB, this state
may be significantly but transiently occupied during recov-
ery from imipramine blockade. The unbinding of the block-
ing imipramine molecule during repolarization thus is rem-
iniscent of the recovery from inactivation in Na channels,
where the inactivated channel must deactivate before it can
recover from inactivation (Kuo and Bean, 1994). Part of the
recovery from inactivation in Shaker K channels may also
proceed via such a “deactivation first” route (Kuo, 1997).
Clinical implications
The plasma concentration of imipramine is usually 0.5–1
M under therapeutic conditions, yet it may be higher than
3 M in overdose (Amsterdam et al., 1980; Benet et al.,
1996). However, there may be as much as 90% plasma
protein binding for imipramine, and thus the free imipra-
mine concentration in the cerebrospinal fluid may be on the
order of 0.1 M in therapeutic conditions. This value is
close to the half-inhibitory concentration (IC50) of imipra-
mine on specific ligand binding to the 5-HT2 (472 nM)
and 1-adrenergic receptors (58 nM; U’Prichard et al.,
1978; Enna and Kendall, 1981), yet it is much smaller than
the dissociation constant between imipramine and the open
KA channels measured here in pH 7.4 (6 M; Fig. 3) or
FIGURE 10 Schematic illustration of some major
conclusions. (A) When the KA channel is opened,
some conformational changes happen at the external
pore mouth to form a receptor for imipramine. The
receptor may consist of one aliphatic site and one to
two aromatic sites. (B) A semiquantitative simplified
gating scheme of the KA channel incorporating the
molecular actions of imipramine. The channel is
opened by depolarization (V) and closed by hyper-
polarization (V). Imipramine binds much more
readily to the open state than to the closed state; hence
there is a much larger “imi” arrow from the open
state than from the closed state. The existence of the
IB state is negligible, and the arrows connecting IB
and I or IB and OB are thus drawn as dashed lines.
Although imipramine binds to the channel at depolar-
ization via the C-O-OB route, the unbinding of imip-
ramine at hyperpolarization seems to happen signifi-
cantly through the CB state, i.e., via the OB to CB to
C route. The “imi” arrow from CB to C is thus larger
than that from OB to O. Also, CB and OB are con-
nected by only a “V” arrow to emphasize that state
CB is significantly present only during the recovery
from imipramine block at hyperpolarization.
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the dissociation constant between imipramine and the de-
layed rectifier channels reported elsewhere (7 M; Wool-
torton and Mathie, 1993). Thus the antidepressant effect of
imipramine is most likely ascribable to its action on the
serotoninergic and adrenergic systems, and the inhibition of
neuronal K current by imipramine probably would be of
clinical significance only in overdose and/or conditions with
extreme alkalosis. Some serious side effect of imipramine in
toxic situations, such as seizures and cardiac arrythmias,
may be related to the drug’s K channel blocking effect and
the subsequent changes in cellular excitability.
This work was supported by a grant from the National Science Council,
Taiwan, R.O.C. (NSC 86-2314-B-002-004-M10).
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